FDA Approves Alzheimer’s Drug Leqembi

  On January 6, 2023, the Food and Drug Administration (FDA) approved a new Alzheimer’s…

Continue Reading ›

NCMS Foundation Webinar: Treating Hepatitis C in Patients with Substance Use Disorders

    Register now for the webinar: "Treating Hepatitis C in Patients with Substance Use…

Continue Reading ›